GPS Wealth Strategies Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$61.1K Sell
1,201
-3,620
-75% -$185K 0.05% 198
2025
Q3
$268K Sell
4,821
-287
-6% -$16.8K 0.03% 286
2025
Q2
$353K Sell
5,108
-432
-8% -$29.4K 0.04% 228
2025
Q1
$385K Sell
5,540
-298
-5% -$24.6K 0.05% 212
2024
Q4
$502K Sell
5,838
-947
-14% -$102K 0.06% 169
2024
Q3
$808K Buy
6,785
+1,013
+18% +$135K 0.11% 132
2024
Q2
$824K Buy
5,772
+847
+17% +$112K 0.12% 116
2024
Q1
$632K Buy
4,925
+1,578
+47% +$188K 0.1% 135
2023
Q4
$346K Buy
3,347
+1,215
+57% +$120K 0.06% 186
2023
Q3
$194K Buy
2,132
+82
+4% +$7.22K 0.04% 250
2023
Q2
$166K Buy
2,050
+1,564
+322% +$128K 0.03% 264
2023
Q1
$38.6K Buy
+486
New +$34.5K 0.01% 531
2022
Q4
Sell
-660
Closed -$33K 762
2022
Q3
$33K Buy
660
+4
+0.6% +$214 0.01% 512
2022
Q2
$37K Buy
656
+4
+0.6% +$222 0.01% 501
2022
Q1
$36K Hold
652
0.01% 478
2021
Q4
$37K Hold
652
0.01% 468
2021
Q3
$31K Buy
652
+2
+0.3% +$97 0.01% 490
2021
Q2
$27K Buy
650
+6
+0.9% +$233 0.01% 532
2021
Q1
$21K Buy
+644
New +$22.9K 0.01% 536

Other funds holding NVO

GPS Wealth Strategies Group's NVO Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Novo Nordisk (NVO) stake by 75% in Q4 2025, selling an estimated $185K and leaving 1,201 shares worth $61.1K. The position accounts for 0.05% of the portfolio, ranked #198.

GPS Wealth Strategies Group first reported a position in NVO in Q1 2021 and has held it in 19 quarters since. The position peaked at $824K in Q2 2024. 1,419 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • GPS Wealth Strategies Group held 1,201 shares of Novo Nordisk worth $61.1K as of Q4 2025.
  • GPS Wealth Strategies Group sold 3,620 Novo Nordisk shares in Q4 2025, an estimated $185K.
  • Novo Nordisk made up 0.05% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #198 holding.
  • GPS Wealth Strategies Group first reported a position in Novo Nordisk in Q1 2021 and has held it in 19 quarters since.
  • GPS Wealth Strategies Group's Novo Nordisk position peaked at $824K in Q2 2024.
  • 1,419 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.